当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析

科前生物

(688526)

  

流通市值:83.67亿  总市值:83.67亿
流通股本:4.66亿   总股本:4.66亿

科前生物(688526)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.19亿元,每股收益0.47元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益405502.64万元,未分配利润217716.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产457533.93万元,负债52031.29万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入487,290,650.57245,188,828.52941,923,862.86665,506,663.22
营业总成本257,541,676.39133,324,710.25547,793,468.42393,227,605.15
其他经营收益
营业利润253,742,611.24125,673,639.93438,847,655.41297,508,255.32
利润总额253,574,907.97125,495,051438,132,852.89296,811,632.39
净利润219,277,761.2107,786,272.75381,489,646.31260,007,447.22
每股收益
其他综合收益50,736,402.8315,356,455.6-42,473,821.86-7,555,091.9
综合收益总额270,014,164.03123,142,728.35339,015,824.45252,452,355.32
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,488,160,848.662,581,193,766.692,473,078,015.082,396,570,097.09
非流动资产:
非流动资产合计2,087,178,432.882,058,360,711.972,022,743,900.982,035,394,753.66
资产总计4,575,339,281.544,639,554,478.664,495,821,916.064,431,964,850.75
流动负债:
流动负债合计435,314,172.13484,790,463.33463,498,149485,279,988.47
非流动负债:
非流动负债合计84,998,694.4189,673,839.5189,300,556.188,012,962.27
负债合计520,312,866.54574,464,302.84552,798,705.1573,292,950.74
所有者权益(或股东权益):
归属于母公司股东权益合计4,053,591,441.344,063,487,267.593,940,969,7013,857,235,244.36
股东权益合计4,055,026,4154,065,090,175.823,943,023,210.963,858,671,900.01
负债和股东权益合计4,575,339,281.544,639,554,478.664,495,821,916.064,431,964,850.75
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计488,335,269.01315,702,694.25880,495,177.8684,071,524.53
经营活动现金流出小计314,009,274.33175,664,858.92487,813,365.48410,980,647.73
经营活动产生的现金流量净额174,325,994.68140,037,835.33392,681,812.32273,090,876.8
投资活动产生的现金流量:
投资活动现金流入小计674,042,015.34184,593,447.791,376,379,491.94939,841,847.1
投资活动现金流出小计613,201,871.38267,069,313.831,279,792,231.11911,560,328.8
投资活动产生的现金流量净额60,840,143.96-82,475,866.0496,587,260.8328,281,518.3
筹资活动产生的现金流量:
筹资活动现金流入小计17,692,584-121,791,961.5797,000,000
筹资活动现金流出小计201,007,316.381,105,814.69624,968,953.77562,226,184.63
筹资活动产生的现金流量净额-183,314,732.38-1,105,814.69-503,176,992.2-465,226,184.63
汇率变动对现金及现金等价物的影响-505,291.59-7,459.4917,728.85-11,538.76
现金及现金等价物净增加额51,346,114.6756,448,695.11-13,890,190.2-163,865,328.29
期末现金及现金等价物余额594,824,707.41599,927,287.85543,478,592.74393,503,454.65
补充资料:
现金及现金等价物的净增加额51,346,114.67--13,890,190.2-
最新报告期:2025-09-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
招商证券施腾,朱卫华0.951.091.272025-09-01
华安证券王莺,万定宇0.931.181.332025-09-01
国海证券熊子兴,程一胜1.021.211.392025-08-28
民生证券徐菁0.981.181.282025-08-28
天风证券吴立,陈潇0.961.111.362025-08-27
TOP↑